Результаты поиска

Emergency department-initiated palliative care for advanced cancer patients: protocol for a pilot randomized controlled trial.

BackgroundFor patients with advanced cancer, visits to the emergency department (ED) are common. Such patients present to the ED with a specific profile of palliative care needs, including burdensome symptoms such as pain, dyspnea, or vomiting that cannot be controlled in other settings and a lack of well-defined goals of care. The goals of this study are: i) to test the feasibility of recruiting, enrolling, and randomizing patients with serious illness in the ED; and ii) to evaluate the impact of ED-initiated palliative care on health care utilization, quality of life, and survival.Methods/de

Совпадение в полном тексте источника
… Patient Interview Use of formal home care | Yes/no, Type of services, h/week | Patient Interview Primary caregiver | Name and relationship/none | Patient Interview Advance directives | Living will, health care proxy, power of attorney for health care/none | Patient Interview Medical insurance | Medicare, Medicaid … , Medicaid/Medicare managed care, Medicare managed care, traditional indemnity, self-pay, other | Administrative database, Medical Record Table 3 Dependent variables Variable | Measurement/Instrument | Source Primary Dependent Variables Rate and timing of palliative care consultation | Yes/No; Days …

Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval.

The Janus kinase inhibitor ruxolitinib is approved for the treatment of myelofibrosis (MF) and improved overall survival (OS) versus control therapy in the phase 3 COMFORT trials. The aim of this retrospective analysis was to examine the real-world impact of ruxolitinib on OS in patients with MF. The US Medicare Fee-for-Service claims database (parts A/B/D) was used to identify patients with ≥ 1 inpatient or ≥ 2 outpatient claims with an MF diagnosis (January 2010-December 2017). Eligible patients with MF were ≥ 65 years old (intermediate-1 or higher risk based on age). Patients were divided i

Совпадение в полном тексте источника
… Data availability The data described in this paper are sourced from Centers for Medicare and Medicaid Services (CMS) Medicare FFS claims and enrollment data. The analytic file constructed for this analysis cannot be shared due to restrictions set forth in the governing Data Use Agreement with CMS. … Associated Data Data Availability Statement The data described in this paper are sourced from Centers for Medicare and Medicaid Services (CMS) Medicare FFS claims and enrollment data. …

Do Proposed Quality Measures for Carpal Tunnel Release Reveal Important Quality Gaps and Are They Reliable?

BACKGROUND: The American Academy of Orthopaedic Surgeons recently proposed quality measures for the initial surgical treatment of carpal tun … tunnel releases in the database (5+, 10+, 15+, 20+, 25+, and 30+). Like the Centers for Medicare & Medicaid Services (CMS), we considered a measure "topped out" if median performance was greater than 95%, meaning the opportunity for further quality improvement is low. We calculated the surgeon-level beta-binomial SNR and SSR for each measure, each stratif …

Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.

Autologous Chimeric antigen receptor (CAR) T-cell therapies have demonstrated substantial efficacy in patients with relapsed or refractory hematologic malignancies; however, their implementation has been constrained by regulatory barriers. Risk Evaluation and Mitigation Strategies (REMS), mandated by the U.S. Food and Drug Administration (FDA), were initially implemented to mitigate risks associated with cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and other treatment-related toxicities. On 27 June 2025, the FDA removed REMS requirements for

Совпадение в полном тексте источника
… Insurance status in particular has been shown to strongly affect survival, with Medicaid and self-pay patients experiencing significantly poorer results despite similar toxicity rates [ 27 ]. … Medicare, Medicaid, and commercial insurers should revise prior-authorization criteria, support decentralized follow-up, and fund temporary lodging when relocation is necessary. …

Disparities in Palliative and Hospice Care and Completion of Advance Care Planning and Directives Among Non-Hispanic Blacks: A Scoping Review of Recent Literature.

ObjectivesPublished research in disparities in advance care planning, palliative, and end-of-life care is limited. However, available data points to significant barriers to palliative and end-of-life care among minority adults. The main objective of this scoping review was to summarize the current published research and literature on disparities in palliative and hospice care and completion of advance care planning and directives among non-Hispanc Blacks.MethodsThe scoping review method was used because currently published research in disparities in palliative and hospice cares as well as adva

Совпадение в полном тексте источника
… Author(s) and year published | Sample size and participants | Research design | Types of disparities addressed and results Yang, A., et al. (2020). 4 | 349 advanced colorectal cancer patients | Retrospective study of cancer registry and linked Medicaid data | No significant differences in hospice enrollment … Hospice services are covered by most insurance providers, as well as Medicare and Medicaid. 151 The recognition in 2006 of hospice and palliative medicine as its own medical subspecialty underlined the importance of palliative care to the practice of medicine. 157 Medical educators now more than ever …

Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study.

BackgroundMany recently approved medications to manage multiple myeloma (MM) are oral, require supportive medications to prevent adverse effects, and are taken under complex schedules. Medication adherence is a concern; however, little attention has been directed toward understanding adherence in MM or associated barriers and facilitators. Advanced sensored medication devices (SMDs) offer opportunities to intervene; however, acceptability among patients with MM, particularly African American patients, is untested.ObjectiveThis study aimed to explore patients' (1) perceptions of their health be

Совпадение в полном тексте источника
… Consistent with the demographics of the larger patient population seen in this setting, the majority of participants were covered by government-issued insurance (Medicaid or Medicare). … Conversely, a 40-year-old single African American female was interested in working but feared losing Medicaid coverage if she returned to work. This was complicated by the fact that historically she had not found positions that offered employer-based health insurance. …

Резюме докладов 2017 Ежегодное совещание Общества общей внутренней медицины.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… The APCD aggregates medical claims each year for private payers and Medicaid in the Massachusetts. … Patients who had calculable CMG’s were older, prescribed more medications, and more likely to have Medicare or Medicaid coverage, versus patients without a CMG. …

Increasing equitable access to telehealth oncology care in the COVID-19 National Emergency: Creation of a telehealth task force.

IntroductionTelehealth (TH) utilization in cancer care prior to COVID-19 was variable. Research highlights disparities in access determined by socioeconomic factors including education, income, race, and age. In response to COVID-19 and these disparities, we assessed the impact of a personalized digital support structure, the Telehealth Task Force (TTF), to reduce disparities in TH.MethodsWe performed a retrospective review of cohorts between January 1, 2020 and August 30, 2020: Pre (TH use with basic telephone support), Intervention (TH access with TTF), and Post (TH access after TTF initiati

Совпадение в полном тексте источника
… A hallmark of the COVID‐19 pandemic has been the rapid uptake of telehealth (TH), defined by the Centers for Medicare and Medicaid Services as the ability to talk with a clinician live via phone or video chat, send, and receive e‐messages with a clinician, or use remote monitoring so a clinician can … Retrieved January 25, 2022, from https://www.asco.org/sites/new‐www.asco.org/files/content‐files/advocacy‐and‐policy/documents/2021‐CertificationPilotOMH.pdf 23 Centers for Medicare and Medicaid Services . ( 2021 ). OCM Quality Measures Guide . …

The impact of radiation treatment planning technique on unplanned hospital admissions.

PurposeTreatment burdens and toxicities related to palliative radiation therapy (RT) may lead to unplanned hospital admissions (UHAs). The likelihood for these toxicities may be related to treatment technique. We compared rates of UHA between patients receiving nonconformal (2-dimensional) and conformal (3-dimensional or higher) radiation treatments to bone metastases involving the vertebral column.Methods and materialsWe retrospectively analyzed patients treated with RT for bone metastases at a single tertiary care center between 2010 and 2017. We compared rates of RT-related UHA within 90 da

Совпадение в полном тексте источника
… 23 (16.5) | 25 (13.4) | 0.199 Breast | 39 (12.0) | 14 (10.1) | 25 (13.4) | Genitourinary | 45 (13.8) | 18 (12.9) | 27 (14.4) | Hematologic | 86 (26.4) | 40 (28.8) | 46 (24.6) | Lung | 65 (19.9) | 29 (20.9) | 36 (19.3) | Other | 43 (13.2) | 15 (10.8) | 28 (15.0) | Insurance type (%) | | | | Medicaid … (0.03-1.96) | .1806 Genitourinary | 0.91 (0.28-2.94) | .8706 | 0.87 (0.26-2.94) | .8235 Hematologic | 0.18 (0.04-0.88) | .0342 | 0.17 (0.03-0.82) | .0273 Lung | 0.88 (0.30-2.59) | .8209 | 0.77 (0.27-2.17) | .6203 Other | 0.18 (0.02-1.51) | .1141 | 0.18 (0.02-1.49) | .1112 Insurance | | .5710 | | Medicaid …

Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.

PROBLEM: As of December 31, 2008, an estimated 663,084 persons were living with a diagnosis of human immunodeficiency virus (HIV) infection … alth insurance or coverage during the 12 months before the interview; of these, 45% reported having Medicaid, 37% reported having private health insurance or coverage through a health maintenance organization, and 30% reported having Medicare. A total of 3,091 (85%) of the participants were currently taking antiretroviral medications. Among 3,609 participa …

Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis.

BACKGROUND: Limited information exists on the healthcare resource utilization (HCRU) associated with real-world natalizumab used as a first-line (1L) versus later-line (2L+) treatment in multiple sclerosis (MS). OBJECTIVES: To describe natalizumab use in newly diagnosed MS patients treated as 1L or 2L+ and evaluate unadjusted annualized relapse rates (ARR) and MS-related HCRU before and after treatment initiation. DESIGN: This retrospective observational study utilized Komodo Health Sentinel claims data from October 2015 to August 2022. The study included adults diagnosed with incident MS wh

Совпадение в полном тексте источника
… Demographic variables measured at index date included age, sex, index year, region, insurance payer type (e.g. commercial, Medicare, Medicaid), race and ethnicity. … 32 (8.1%) Region 0.29  Midwest 274 (23.3%) 93 (23.6%)  Northeast 299 (25.5%) 84 (21.3%)  South 376 (32.0%) 148 (37.6%)  West 189 (16.1%) 56 (14.2%)  Puerto Rico 2 (0.2%) 1 (0.3%)  (Missing) 34 (2.9%) 12 (3.0%) Payer channel <0.001  Commercial 713 (60.7%) 215 (54.6%)  Medicare 19 (1.6%) 5 (1.3%)  Medicaid …

Реальные результаты лечения чернокожих, испаноязычных, азиатов и белых пациентов с множественным склерозом лечатся с Натализумбом.

Множественный склероз (MS) является разнородным заболеванием, которое может проявляться по-разному среди расовых/этнических групп и которое влияет на реакцию на лечение синдицирующими заболеваниями (ДМТ). Данные об эффективности дородовой помощи (NTZ) у лиц с НР (PwMS) по признаку расы/этнической принадлежности являются ограниченными. ЦЕЛЬ: Цель настоящего исследования заключалась в оценке эффективности НТЗ в случае рецидива и его темпов, а также в оценке связанных с НР проблем и расходов в области здравоохранения в чернокожих, испаноязычных, азиатских и белых районах. МЕТОДЫ: Это был ретроспе

Совпадение в полном тексте источника
… 39.7 (10.9) 37.5 (10.1) 40.3 (12.1) 42.6 (10.9) Age group, years, n (%)  18–29 117 (18.5) 94 (24.6) 9 (18.4) 274 (12.6)  30–49 379 (60.0) 232 (60.7) 28 (57.1) 1275 (58.5)  50–64 136 (21.5) 56 (14.7) 12 (24.5) 632 (28.9) Insurance type, n (%)  Commercial 256 (40.5) 214 (56.0) 35 (71.4) 1430 (65.6)  Medicaid … In fact, Black and Hispanic PwMS were nearly twice as likely to be on federally funded insurance (i.e., Medicaid, Medicare) than White PwMS. …

Однонаправленное картирование ICD-8 в адрес ICD-10 - коды для согласованного продольного анализа болезней.

Периодические пересмотры международной классификации болезней (МКБ) обеспечивают, чтобы классификация отражала новые виды практики и знания; однако это осложняет ретроспективные исследования, поскольку диагнозы кодируются в различных вариантах. Для изучения траектории продольных заболеваний важным инструментом и всеобъемлющим картографированием между ICD-8 и ICD-10 до сих пор отсутствовали. В этом исследовании мы почерпнем все ICD-8 Коды заболеваемости ICD-10 в расширенной датской версии МКБ. Мы спланировали ICD-8 коды для ICD-10, используя много--one система, построенная на общих картах эквив

Совпадение в полном тексте источника
… Centers for Medicare & Medicaid Services. General equivalence mappings, documentation for technical users. 2016. 19. World Health Organization. International Classification of Diseases, Translator, Ninth and Tenth Revisions. Geneva : World Health Organization, 1997. 20. Danish Health Authority. … Centers for Medicare & Medicaid Services. diagnosis code set general equivalence mappings, ICD-10-CM to ICD-9-CM and ICD-9-CM to ICD-10-CM, Documentation and User’s Guide. 2016. 28. World Health Organization - Division of Mental Health. …

Abstracts from the 37th Annual Meeting of the Society of General Internal Medicine, 2014, San Diego, CA, USA.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Medicaid initiatives were typically large statewide programs (median 224,040 patients) run directly by state Medicaid agencies. Multi-payer initiatives included a median of six health plans (IQR 4–7) with a median of 187,343 patients, and 68 practices. … These initiatives included commercial health plans, Medicare and Medicaid. Formal PCMH recognition was required by 69 % of initiatives. …

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States.

PurposeCardiac dysfunction is common in amyloid light-chain (AL) amyloidosis, a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to examine economic/clinical disease burden in hospitalized cardiac amyloidosis patients.Patients and methodsCardiac amyloidosis patients ≥18 years old hospitalized between 2014 and 2016 were identified in claims if they had ≥1 inpatient claim consistent with amyloidosis and evidence of cardiac dysfunction. Descriptive statistics were reported.Results3239 cardiac amyloidosis patients [1795 (55.4%) with concurr

Совпадение в полном тексте источника
… Payment source included Medicare, Medicaid, commercial, or other. … Race , n (%) | | | White | 1012 (70.1) | 1049 (58.4) | 2061 (63.6) African American | 256 (17.7) | 488 (27.2) | 744 (23.0) Other | 152 (10.5) | 237 (13.2) | 389 (12.0) Unknown | 24 (1.7) | 21 (1.2) | 45 (1.4) Primary payer type , n (%) | | | Medicare a | 1133 (78.5) | 1377 (76.7) | 2510 (77.5) Medicaid …

Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score.

Background and objectives: Little is known about outcome improvements and disparities in cardiac arrest and active cancer. We performed the first known AI and propensity score (PS)-augmented clinical, cost-effectiveness, and computational ethical analysis of cardio-oncology cardiac arrests including left heart catheterization (LHC)-related mortality reduction and related disparities. Materials and methods: A nationally representative cohort analysis was performed for mortality and cost by active cancer using the largest United States all-payer inpatient dataset, the National Inpatient Sample,

Совпадение в полном тексте источника
… (Premise 2) There appear to be significant disparities among patients with active cancer in the prevalence of fatal out-of-hospital cardiac arrest as patients of particular racial minorities, lower income, Medicaid, and no insurance may be more likely to present to the hospital. … Our results suggest among post-arrest patients that Hispanic, African American, lower income, Medicaid, uninsured, and more urban patients with active cancer may suffer from higher undiagnosed or under-managed chronic comorbidities. …

Risk of rehospitalization due to Clostridioides difficile infection among hospitalized patients with Clostridioides difficile: a cohort study.

BackgroundReducing rehospitalization has been a primary focus of hospitals and payors. Recurrence of Clostridioides difficile infection (CDI) is common and often results in rehospitalization. Factors that influence rehospitalization for CDI are not well understood.ObjectiveTo determine the risk factors that influence rehospitalization caused by CDI.DesignA retrospective cohort study from January 1, 2018, to December 31, 2018, of patients aged ≥18 who tested positive for C. difficile while hospitalized.SettingAcademic hospital.MethodsThe risk of rehospitalization was assessed across exposures d

Совпадение в полном тексте источника
… treatment selection, administration of other systemic antibiotics, reduced immune response, advancing age, or severe underlying disease. 6 Patients with recurrence may require rehospitalization due to the severity of the disease. 7 Rehospitalizations are a particular focus of the Centers for Medicare and Medicaid … Centers for Medicare and Medicaid Services (CMS) H. …

Emergency Department Utilization of Adult Cancer Patient in Korea: A Nationwide Population-Based Study, 2017-2019.

PurposeThe current study aimed to identify the overall characteristics of cancer-related emergency department (ED) visits by adult in Korea, including analyses of factors associated with ED stay time and outcomes nationwide.Materials and methodsWe collected data on cancer-related ED visits from the National Emergency Department Information System (NEDIS) database between 2017 and 2019.ResultsED visits by cancer patients comprised 5.5% (667,935 visits) of total ED visits from 2017 to 2019, which was slightly higher than in other counties. Patients with cancer who visited the ED were over 50 yea

Совпадение в полном тексте источника
… The variables of insurance status (NHI, Medicaid, uninsured), type of ED (regional emergency center, local emergency center, local emergency institution), region of ED (metropolitan city, province), mode of arrival (ambulance, non-ambulance), time of arrival (9 am –6 pm , 6 pm –9 am ), LOS in the ED … ) | 785 (17.0) | 263 (14.1) | Sex Male | 257,671 (57.2) | 124,574 (59.1) | 3,433 (74.2) | 1,396 (74.7) | < 0.001 Female | 192,973 (42.8) | 86,149 (40.9) | 1,196 (25.9) | 472 (25.3) | Insurance status National Health Insurance | 4,159 (92.2) | 182,883 (86.8) | 4,314 (89.3) | 1,660 (88.9) | < 0.001 Medicaid …

Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia.

Tisagenlecleucel is a first-in-class chimeric antigen receptor (CAR) T-cell therapy approved by the US Food and Drug Administration in 2017 for relapsed/refractory (RR) acute lymphoblastic leukemia (ALL) in patients up to 25 years of age. Tisagenlecleucel is an autologous T-cell therapy that is genetically engineered with a lentiviral vector to seek and eliminate CD19-expressing B cells throughout the patient's body and retain antitumor immune surveillance following remission. This groundbreaking cellular therapy brings unprecedented single-agent efficacy to patients with RR ALL, citing comple

Совпадение в полном тексте источника
… A lengthy prior approval process will be necessary to ensure insurance coverage for CTL019 given its $475,000 price tag; however, the manufacturer has stated that Medicaid will not have to pay for the drug for Medicaid-covered children who do not show response by day 30 ( Skinner, 2017 ). …

Factors influencing cancer patients' experiences of care in the USA, United Kingdom, and Canada: A systematic review.

The extent to which individual and structural factors influence cancer patients' reports of their experiences are not yet well understood. We sought to identify which groups of patients consistently report poorer experiences and whether structural care factors might also be associated with better or worse reports. We conducted a systematic review of literature in PubMed and Web of Science with the date of last search as 27th of February 2022 following PRISMA guidelines. We focused on studies from three established population-based surveys datasets and instruments. After screening 303 reference

Совпадение в полном тексте источника
… . | 1 | Patients who were enrolled in both Medicare and Medicaid tended to be poorer, have more functional and cognitive limitations, and have more medical needs compared with beneficiaries enrolled in Medicare or Medicaid alone. … Cancer patients who were enrolled in both Medicare and Medicaid reported better care experiences with prescription drug plans and health plans than patients enrolled in Medicare-only. …